Indegene Limited has announced that its subsidiary, Indegene Healthcare UK Limited, has signed a definitive Trade and Asset Purchase Agreement to acquire the business and assets of Trilogy Writing and Consulting Limited. The transaction, valued at GBP 1,90,679, is structured as a going concern purchase. As both entities are under common control and indirectly wholly owned by the company, the deal has been executed on an arm’s length basis.
Strategic Business Consolidation
On April 01, 2026, Indegene Healthcare UK Limited successfully executed an agreement to purchase the trade and business operations of Trilogy Writing and Consulting Limited. This move represents a strategic consolidation of business assets within the group. The acquisition ensures that the business continues to operate as a going concern, maintaining seamless service delivery.
Transaction Details
The total consideration for this asset acquisition is GBP 1,90,679. This transaction follows the previous acquisition of the entire issued share capital of the seller, which was formally communicated to the market on March 1, 2026. Both the buyer and the seller operate within the same group of companies, with Indegene Limited acting as the indirect parent entity for both. The company has confirmed that this transaction is conducted in compliance with standard corporate governance and arm’s length pricing protocols.
Source: BSE
